Country: Ireland
Bahasa: Inggeris
Sumber: HPRA (Health Products Regulatory Authority)
TRAMADOL HYDROCHLORIDE, PARACETAMOL
Grünenthal Ltd
N02AJ13
TRAMADOL HYDROCHLORIDE, PARACETAMOL
37.5/325 Milligram
Film Coated Tablet
Product subject to prescription which may not be renewed (A)
opiods in combination with non-opiod analgesics
Authorised
2008-02-15
Material No. CMO Mat. No. Class. No. Customer Mat. No. Laetus Code Colors & Collating Marks 93023396 – 50/036/23 – 93020310 9 GI IXPRIM FILMTABLETTEN EN IRL 20.07.2017 V3 | CPR Previous Mat. No. Product Name Date/Version 8 pt Font Size Dimension 137 X 297 MM Grain Direction 297 MM BLACK ................. 7 1. WHAT IXPRIM IS AND WHAT IT IS USED FOR IXPRIM is a combination of two analgesics, tramadol and paracetamol, which act together to relieve your pain. IXPRIM is intended for use in the treatment of moderate to severe pain when your doctor recommends that a combination of tramadol and paracetamol is needed. IXPRIM should only be taken by adults and adolescents over 12 years. 2. WHAT YOU NEED TO KNOW BEFORE YOU TAKE IXPRIM DO NOT TAKE IXPRIM – if you are allergic to tramadol hydrochloride, paracetamol or any of the other ingredients of this medicine (listed in section 6); – in acute poisoning with alcohol, sleeping pills, pain relievers or other psychotropic medicines (medicines that affect mood and emotions); – if you are also taking MAO inhibitors (certain medicines used for treatment of depression or Parkinson’s disease) or have taken them in the last 14 days before treatment with IXPRIM; – if you suffer from a severe liver disorder; – if you have epilepsy that is not adequately controlled on your current medicine. WARNINGS AND PRECAUTIONS TALK TO YOUR DOCTOR BEFORE TAKING IXPRIM: – if you take other medicines containing paracetamol or tramadol; – if you have liver problems or liver disease or if you notice your eyes and skin turning yellow. This may suggest jaundice or problems with your bile ducts. – if you have kidney problems; – if you have severe difficulties in breathing for example asthma or severe lung problems; – if you have epilepsy or have already experienced fits or seizures; – if you have recently suffered from a head injury, shock or severe headaches associated with vomiting; – if you are dependent on any medicines including those used to relieve pain, for example m Baca dokumen lengkap
SUMMARY OF PRODUCT CHARACTERISTICS 1 NAME OF THE MEDICINAL PRODUCT IXPRIM 37.5 mg/325 mg, film coated-tablets 2 QUALITATIVE AND QUANTITATIVE COMPOSITION One film-coated tablet contains 37.5 mg tramadol hydrochloride and 325 mg paracetamol Excipients: One film coated tablet contains 1.878 mg lactose monohydrate (= 1.784mg lactose). For the full list of excipients, see section 6.1. 3 PHARMACEUTICAL FORM Film-coated tablet Pale yellow film-coated tablet, marked with the manufacturers logo on one side and ‘T5’ on the other side. 4 CLINICAL PARTICULARS 4.1 THERAPEUTIC INDICATIONS Ixprim tablets are indicated for the symptomatic treatment of moderate to severe pain. The use of Ixprim should be restricted to patients whose moderate to severe pain is considered to require a combination of tramadol and paracetamol (see also Section 5.1). 4.2 POSOLOGY AND METHOD OF ADMINISTRATION _Posology_ The use of Ixprim should be restricted to patients whose moderate to severe pain is considered to require a combination of tramadol and paracetamol. The dose should be adjusted to intensity of pain and the sensitivity of the individual patient. The lowest effective dose for analgesia should generally be selected. The total dose of 8 tablets (equivalent to 300 mg tramadol hydrochloride and 2600 mg paracetamol) per day should not be exceeded. The dosing interval should not be less than six hours. Adults and adolescents (12 years and older) An initial dose of two tablets of Ixprim is recommended Additional doses can be taken as needed, not exceeding 8 tablets (equivalent to 300 mg tramadol and 2600 mg paracetamol) per day. The dosing interval should not be less than six hours. Ixprim should under no circumstances be administered for longer than is strictly necessary (see also section 4.4 - Special warnings and precautions for use). If repeated use or long term treatment with Ixprim is required as a result of the nature and severity of the illness, then careful, regular monitoring should take place (with breaks in the treatment, where p Baca dokumen lengkap